en POLSKI
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2020
vol. 95
 
Share:
Send email
Share:
abstract:
Review paper

Use of the Brief Observation of Symptoms of Autism (BOSA) as a new clinical approach to assessing patients with suspected spectrum disorder during the COVID-19 pandemic

Agnieszka Rynkiewicz
1
,
Roma Vasa
2
,
Izabela Łucka
3
,
Artur Mazur
4

  1. Department of Psychiatry, Institute of Medical Sciences, Medical College of Rzeszów University, Poland
  2. Kennedy Krieger Institute, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, USA
  3. Department of Developmental Psychiatry, Psychotic and Geriatric Disorders, Medical University of Gdańsk, Poland
  4. Department of Paediatrics, Institute of Medical Sciences, Medical College of Rzeszów University, Poland
DOI: https://doi.org/10.5114/polp.2020.103494
Online publish date: 2021/01/30
View full text Get citation
 
PlumX metrics:
COVID-19 has imposed major changes to the delivery of healthcare worldwide. In many settings, healthcare is now predominantly transitioned to telehealth, creating challenges and unique benefits. In 2020, the Centers for Disease Control and Prevention has reported that 1 in 54 children in the U.S. are diagnosed with autism spectrum disorder (ASD). The Brief Observation of Symptoms of Autism (BOSA) is a new clinical approach that has been developed to ensure that patients suspected of ASD can receive valid diagnostic assessments during the pandemic. BOSA is offered when a diagnostician is unable to administer the Autism Diagnostic Observation Schedule – Second Edition (ADOS-2) either because it is not appropriate to administer the ADOS-2 via telehealth or, in person, face coverings confound ASD assessment. Only trained ADOS-2 diagnosticians can administer BOSA, because BOSA relies on ADOS-2 codes. The article describes BOSA to prepare the field for future research during the COVID-19 crisis.
keywords:

COVID-19 pandemic, BOSA, ADOS-2, autism spectrum disorder